Outcomes of elderly patients with stage IIIB-IV non-small cell lung cancer admitted to the intensive care unit

Lung Cancer

Volumn 77, Issue 3, 2012, Pages 600-604

  Bonomi, Marcelo R ^a   Smith, Cardinale B ^a   Mhango, Grace ^a   Wisnivesky, Juan P ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Elderly; Intensive care unit; Lung cancer; Mortality

Indexed keywords

ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER SURVIVOR; DISEASE SEVERITY; FEMALE; GERIATRIC PATIENT; HEART DISEASE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICARE; NEUROLOGIC DISEASE; PATIENT CARE; POPULATION RESEARCH; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SEPSIS; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INTENSIVE CARE UNITS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; NEOPLASM STAGING; PATIENT ADMISSION; SEER PROGRAM; TREATMENT OUTCOME;

EID: 84865159165     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2012.05.103     Document Type: Article

References (30)

1. Yang P., Allen M.S., Aubry M.C., Wampfler J.A., Marks R.S., Edell E.S., et al. Clinical features of 5628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 2005, 128:452-462.
2. SEER Cancer Statistics Review 1975-2004, National Cancer Institute, Bethesda, MD. L.A.G. Ries, M.D. Krapcho, M. Mariotto, A. Miller, B.A. Feuer, E.J. Clegg, L. Horner, M.J. Howlader, N. Eisner, M.P. Reichman, M.B.K. Edwards (Eds.).
3. Bunn P.A., Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider Conclusion. Oncologist 2008, 13(Suppl. 1):37-46.
4. Griffin J.P., Nelson J.E., Koch K.A., Niell H.B., Ackerman T.F., Thompson M., et al. End-of-life care in patients with lung cancer. Chest 2003, 123:312S-331S.
5. Kress J.P., Christenson J., Pohlman A.S., Linkin D.R., Hall J.B. Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 1999, 160:1957-1961.
6. Ewer M.S., Ali M.K., Atta M.S., Morice R.C., Balakrishnan P.V. Outcome of lung cancer patients requiring mechanical ventilation for pulmonary failure. JAMA 1986, 256:3364-3366.
7. Lin Y.C., Tsai Y.H., Huang C.C., Hsu K.H., Wang S.W., Tsao T.C., et al. Outcome of lung cancer patients with acute respiratory failure requiring mechanical ventilation. Respir Med 2004, 98:43-51.
8. Boussat S., El'rini T., Dubiez A., Depierre A., Barale F., Capellier G. Predictive factors of death in primary lung cancer patients on admission to the intensive care unit. Intensive Care Med 2000, 26:1811-1816.
9. Reichner C.A., Thompson J.A., O'Brien S., Kuru T., Anderson E.D. Outcome and code status of lung cancer patients admitted to the medical ICU. Chest 2006, 130:719-723.
10. Roques S., Parrot A., Lavole A., Ancel P.Y., Gounant V., Djibre M., et al. Six-month prognosis of patients with lung cancer admitted to the intensive care unit. Intensive Care Med 2009, 35:2044-2050.
11. Christodoulou C., Rizos M., Galani E., Rellos K., Skarlos D.V., Michalopoulos A. Performance status (PS): a simple predictor of short-term outcome of cancer patients with solid tumors admitted to the intensive care unit (ICU). Anticancer Res 2007, 27:2945-2948.
12. Toffart A.C., Minet C., Raynard B., Schwebel C., Hamidfar-Roy R., Diab S., et al. Use of intensive care in patients with nonresectable lung cancer. Chest 2010.
13. Sharma G., Freeman J., Zhang D., Goodwin J.S. Trends in end-of-life ICU use among older adults with advanced lung cancer. Chest 2008, 133:72-78.
14. Potosky A.L., Riley G.F., Lubitz J.D., Mentnech R.M., Kessler L.G. Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993, 31:732-748.
15. Surveillance E, and End Results (SEER) Program Limited-Use Data (1973-2006), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2007 submission.
16. Klabunde C.N., Potosky A.L., Legler J.M., Warren J.L. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000, 53:1258-1267.
17. Klabunde C.N., Legler J.M., Warren J.L., Baldwin L.M., Schrag D. A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patients. Ann Epidemiol 2007, 17:584-590.
18. AJCC Cancer Staging Manual 2010, S.B. Edge, D.R. Byrd, C.C. Compton, A.G. Fritz, F.L. Greene, A. Trotti (Eds.).
19. Fritz A., Percy C., Jack A. International classification of diseases for oncology 2000, World Health Organization, Geneva, Switzerland. 3rd ed.
20. Virnig B.A., Warren J.L., Cooper G.S., Klabunde C.N., Schussler N., Freeman J. Studying radiation therapy using SEER-Medicare-linked data. Med Care 2002, 40(IV):49-54.
21. Warren J.L., Harlan L.C., Fahey A., Virnig B.A., Freeman J.L., Klabunde C.N., et al. Utility of the SEER-Medicare data to identify chemotherapy use. Med Care 2002, 40(IV):55-61.
22. Adam A.K., Soubani A.O. Outcome and prognostic factors of lung cancer patients admitted to the medical intensive care unit. Eur Respir J 2008, 31:47-53.
23. Soares M., Caruso P., Silva E., Teles J.M.M., Lobo S.M.A., Friedman G., et al. Network obotBRiIC. Characteristics and outcomes of patients with cancer requiring admission to intensive care units: a prospective multicenter study. Crit Care Med 2010, 38:9-15. 10.1097/CCM.1090b1013e3181c0349e.
24. Soares M., Darmon M., Salluh J.I., Ferreira C.G., Thiery G., Schlemmer B., et al. Prognosis of lung cancer patients with life-threatening complications. Chest 2007, 131:840-846.
25. Williams M.D., Braun L.A., Cooper L.M., Johnston J., Weiss R.V., Qualy R.L., et al. Hospitalized cancer patients with severe sepsis: analysis of incidence, mortality, and associated costs of care. Crit Care 2004, 8:R291-R298.
26. Staudinger T., Stoiser B., Mullner M., Locker G.J., Laczika K., Knapp S., et al. Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 2000, 28:1322-1328.
27. Virnig B.A., Marshall McBean A., Kind S., Dholakia R. Hospice use before death: variability across cancer diagnoses. Med Care 2002, 40:73-78.
28. Ford D.W., Nietert P.J., Zapka J., Zoller J.S., Silvestri G.A. Barriers to hospice enrollment among lung cancer patients: a survey of family members and physicians. Palliat Support Care 2008, 6:357-362.
29. Desch C.E., Penberthy L., Newschaffer C.J., Hillner B.E., Whittemore M., McClish D., et al. Factors that determine the treatment for local and regional prostate cancer. Med Care 1996, 34:152-162.
30. Ballard-Barbash R., Potosky A.L., Harlan L.C., Nayfield S.G., Kessler L.G. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996, 88:716-726.